Imbio PHA (4.0.0) vs prolaio eVO2peak Module
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA if your primary need is rapid, automated analysis of CT pulmonary angiogram (CTPA) scans to precisely measure cardiac structures. This tool is ideal for clinicians and radiologists who require objective assessment of right ventricular dilation and accurate RV/LV and PA/Ao ratios to aid in the diagnosis and risk stratification of conditions like pulmonary embolism and pulmonary hypertension. It streamlines workflows by providing automated measurements and reports directly from existing imaging data.
View Imbio PHA (4.0.0) →Choose prolaio eVO2peak Module if…
Choose prolaio eVO2peak Module if you need to estimate peak oxygen consumption (eVO2peak) using real-world patient data from wearable medical sensors for cardiovascular research or ongoing patient care. This solution is best suited for longitudinal monitoring of cardiovascular fitness and risk, leveraging demographic data, ECG, and accelerometry inputs to provide an adjunctive aid in clinical evaluation without requiring traditional exercise stress tests. It enables high-density data collection for a more comprehensive understanding of a patient's cardiovascular status over time.
View prolaio eVO2peak Module →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | prolaio eVO2peak Module |
|---|---|---|
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Cloud |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio PHA (4.0.0)Imbio PHA integrates directly into established radiology workflows by processing CTPA scans and generating DICOM and PDF outputs, minimizing disruption to existing clinical practices. Prolaio eVO2peak Module, while cloud-based, relies on data from third-party wearable sensors, which introduces a distinct data collection and processing workflow that may require new user behaviors and integrations.
Clinical Value
Imbio PHA (4.0.0)Imbio PHA provides direct, quantitative measurements from standard imaging (CTPA) that are critical for the diagnosis and acute risk stratification of conditions like pulmonary embolism and hypertension. Prolaio eVO2peak Module offers an adjunctive estimation of peak oxygen consumption from wearable data, which is valuable for chronic care and research but less directly impactful for acute diagnostic decisions.
Pricing & Value
TieBoth tools require direct contact for pricing information, making it impossible to assess their relative pricing transparency or value proposition without further details.
Enterprise Readiness
Imbio PHA (4.0.0)Imbio PHA offers greater deployment flexibility, supporting cloud, on-premise, or partner integrations, which is crucial for large enterprises with varying IT infrastructure and data governance needs. Both tools are FDA-cleared and HIPAA compliant, demonstrating foundational readiness for clinical environments.
Innovation
prolaio eVO2peak ModuleProlaio eVO2peak Module demonstrates greater innovation by utilizing novel data sources (wearable sensors) and deep learning to estimate a complex physiological parameter (eVO2peak) from real-world patient data. This approach extends beyond traditional clinical data analysis, offering new avenues for cardiovascular assessment.
Support & Docs
Imbio PHA (4.0.0)Imbio PHA clearly outlines its comprehensive support structure, including 24/7/365 availability, multiple contact methods, and explicit mention of user manuals and product documentation. Prolaio's support information is less detailed for clinical users of the module, focusing more on patient-centric monitoring support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | prolaio eVO2peak Module |
|---|---|---|
| Name | Imbio PHA (4.0.0) | prolaio eVO2peak Module |
| Company | Imbio (a subsidiary of 4DMedical) | Prolaio |
| Key Functionality | Automated measurement of cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. | Estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care. |
| Input Data | CT pulmonary angiogram (CTPA) scans | Demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors |
| Output Data | Annotated DICOM images and PDF summary reports | Information as an adjunctive aid in clinical evaluation (eVO2peak estimation) |
| Supported Languages | Arabic, Dutch, English, French, German, Italian, Portuguese, Russian, Spanish. | Not specified |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and prolaio eVO2peak Module.